A physiologically active protein product from which thyroxine (IV) can be isolated was prepared from milk casein by W. Ludwig and P. von Mutzenbecherl in 1939, by treatment of this protein with iodine under carefully controlled conditions. The experimental technique of these workers was repeated by C. R. Harington and Rosalind V. P. Rivers2 in England, and the original findings of the German investigators were confirmed in every respect. There appears to be no doubt as to the correctness of the conclusions reached by these independent workers and it, therefore, becomes a matter of immediate chemical interest to consider any possible mechanism of reaction whereby such an important biochemical transformation can theoretically be brought about.
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That iodine under proper experimental conditions is capable of affecting an oxidative coupling of two molecules of 3,5-diiodotyrosine to form a thyroxine molecule was established later by P. von Mutzenbecher,3 who accomplished this change successfully by oxidation of 3,5-diiodotyrosine with hypoiodous acid formed during prolonged incubation of this a-aminoacid in -alkaline solution at 37°. These experiments were repeated and the results reported by P. von Mutzenbecher3 were confirmed by P. Block, Jr.," in 1940. The original hypothesis advanced by C. R. Harington2 that the biogenic synthesis of thyroxine probably results from the iodination of tyrosine functioning in the protein molecule through the intermediate stage of 3,5-diiodotyrosine must, therefore, receive careful consideration in the light of these most interesting results.
Biogenic Synthesis:
Tyrosine -3,5-Diiodotyrosine --Thyroxine.
The authors have repeated the incubation experiments of P. von Mutzenbecher3 using synthetical 3,5-diiodotyrosine of the highest purity, and have confirmed his conclusion that thyroxine is a product of reaction under specific experimental, conditions. If the postulation be correct that thyroxine is produced here as a result of oxidation of the 3,5-diiodotyrosine by hypoiodous acid (HIO) formed from this a-amino acid in the alkaline solution, then the yield of thyroxine should theoretically vary according to the quantity of active hypoiodate present in the solution. The authors, therefore, modified P. von Mutzenbecher's technique3 by adding hypoiodate to the a-aminoacid solution in molecular proportion with the result that the yield of thyroxine was slightly increased as postulated.
After applying several oxidation experiments with successful results, and after giving more attention to the nature of the secondary products of the reaction, the authors have been able to formulate a reaction mechanism which has not hitherto been presented to explain the formation of thyroxine (IV) from 3,5-diiodotyrosine (I). Our scheme of transformation is based on the results obtained in the fundamental studies of R. Pummerer5 and coworkers dealing with the manner of oxidation of o-and p-substituted phenols in alkaline solution. We submit, therefore, the following graphical representation of this reaction (table 1) leading to the formation of thyroxine (IV) from 3,5-diiodotyrosine (I). (I) (table 1) , is compared structurally with the corresponding oxidation product of p-cresol (VIII) (table 2), it may be seen that the internuclear condensation or rearrangement, which takes place in the formation of the tetrahydro-benzofurane (IX) from the pquinolether (VIII), is precluded in the case of the corresponding hypothetical 3,5-diiodotyrosine derivative (III). The substitution of iodine atoms in both nuclear positions ortho to the ether-bound oxygen atom in (III) prevents any possibility of cyclization of this compound. Hence, stabilization of the system expressed by structure (III) must follow one of two courses namely, (1) molecular dissociation with loss of one alanine side chain and formation of thyroxine (IV) and iminopyruvic acid or, (2) hydrolysis of (III) with production of serine, HOCH2CH(NH2)COOH and thyroxine (IV). The results obtained by experimentation to date lead the authors to the conclusion that the formation of thyroxine (IV) from 3,5-diiodotyrosine (I) as described above is an oxidation process, and that the correctness of the reaction-mechanism postulated is supported by the facts that pyruvic acid8 (V) and ammonia have been identified by the authors as secondary products of the reaction. Thus far, the authors have been unable to detect the presence of the a-aminoacid-serine as a product of the oxidation reactions. A thorough search for other products of reaction is now in progress.
Summary.-It is a well-known fact that thyroxine and also 3,5-diiodotyrosine slowly undergo decomposition especially when exposed to sunlight, in weakly alkaline solution with formation of hypoiodous acid (HIO).9 This halogen acid interacts slowly with 3,5-diiodotyrosine to form thyroxine,3' 4but thus far no mechanism of reaction has been approved to explain this biochemical change. The authors have repeated the work of previous investigators of this important change, and have found that not only thyroxine but also pyruvic acid and ammonia are formed as secondary products of reaction. The discovery of pyruvic acid (V) as a product of this oxidation reaction has made possible the postulation of a simple and plausible mechanism to explain the formation of the thyroxine. The study of this problem is being continued and a discussion of the experimental technique and analytical results will be published elsewhere. 5(a) Pummerer, R., and Frankfurter, F., Ber., 47, 1472 Ber., 47, -1493 Ber., 47, (1914 .
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Experimental.-The substances I to IV and the rabbit antiserum homologous to azo sheep serum made with arsanilic acid were prepared by methods described elsewhere.lC The complement of the antiserum was inactivated by heating at 570 for 30 minutes.
The amboceptor was prepared (by Mr. Carol Ikeda) by giving rabbits ten injections of 1 or 2 ml. of a 10% sheep cell suspension over a period of 3 weeks. The rabbits were bled on the seventh, eighth and ninth days after
